News About: Pharm. Industry
Bayer Schering appoints new chief for Philippines branchBayer Schering Pharma announced on September 1 that Noh Sang-kyung, ex-vice president for strategy and development in Asia-Pacific region, was appointed as its new president for...
|
Weak won drives up cGMP construction costs
The weak won is taking a toll on the pharmaceutical industry, with its negative impact on the construction costs of cGMP plant, experts said.
A weak local currency drives up local machinery and equipment costs with...
Green Cross launches sibutramine genericGreen Cross Corp. has launched its Reformer-S (sibutramine) tablets for treatment of obesity.
The local market size for sibutramine posted 76 billion won with an annual growt...
|
Generic battle for Ultracet
With many global makers' blockbuster products coming off patent, the race for the generic drug market is set to be in full force in the second half of this year.
Recently, the drug at the center of attention is the...
Korean sibutramine generics increase market share
Korean sibutramine generics increase market share
Korean-made sibutramine preparations are increasing their market share
in the first half of this year, an industry report showed recen...
Wholesalers on high alert over Samsung entry into logistic business
Pharmaceutical wholesalers are in dilemma on how to cope with Samsung Mulsan’s possible advancement into the local logistic sector.
A task force team of the Korea Association of Pharmaceutical Association has recen...
Concerns growing over controversial rebates
The controversy over rebates and the “right'' price for drugs have been ongoing topics of debate as Korea’s leading pharmaceutical firms are in more fierce competition to raise their revenues.
Consumers and civic g...
Daewoong to stop anti-obesity campaign
Daewoong Pharm says it will not continue to conduct its pharmacy-oriented “Say Health Diet” program for pharmacy.
Daewoong said in a statement that the company apologizes for any misunderstanding associated with it...
Ethical-oriented sales policy triggers discontent from OTC wholesalers
Pharmaceutical companies and OTC-handling wholesalers are expected to continue their clash over service, returned goods and rebates as a number of drug makers have selected their sales managers who have been chiefly i...
Choong-wae, Sanwa to develop SK-0403 for treatment of diabetesChoong-wae Pharm has entered into an exclusive licensing agreement with Sanwa Kagaku Kenkyusho Co., Ltd. (Sanwa) to develop and commercialize SK-0403 (dipeptidyl peptidase-IV in...
|
